Morgan Stanley Stock News

Photo Illustration by The Daily Beast/Linkedin Better.com CEO Vishal Garg is taking time off effective immediately, as employees revolt over a mass layoff he executed in brutal fashion at the start of the month. In an email obtained by The Daily Beast, the companys board of directorswhich had previously granted Garg exceptionally wide latitude announced that it will bring in a third party firm to conduct a leadership and cultural assessment. Betters chief financial officer Kevin Smith, who recently joined from Morgan Stanley, will manage day-to-day operations in the interim. Read more at The Daily Beast.

Moderna Slides As Flu Vaccine Data Disappoint Moderna shares slumped yet again in premarket trading Friday after the company released trial results for its flu vaccine that were swiftly denounced by Wall Street analysts. Shares of the pharmaceutical heavyweight, which saw its profile and revenue explode thanks to its development of one of the first mRNA-based COVID vaccines, were down more than 10% in premarket trading Friday after Morgan Stanley warned the early-stage flu vaccine trial data had disappointed analysts who were looking for "clearly better efficacy." Instead, the Moderna shot appears to only match results from Sanofis Fluzone HD. Moderna management "didn''t provide detailed reactogenicity data or data on seroconversion which we expect in the slides from the call," said analyst Matthew Harrison, who has an equal-weight rating on the stock with a price target $313. The news sent Moderna shares tumbling toward their lows from early last month, when the firm''s Q3 earnings report, particularly its sales guidance for the coming year, missed Wall Street expectations.

(PR-inside.com) LOS ANGELES, CA / ACCESSWIRE / December 10, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Goldman Sachs Group Inc. and Morgan Stanley on behalf of shareholders in Gaotu Techedu Inc. ("Gaotu" or "the Company") (NYSE:GOTU) f/k/a GSX Techedu Inc. ("GSX") (NYSE:GSX) for violations of the securities laws. Investors who purchased the Company''s securities between March 22, 2021 and March 29, 2021, inclusive (the ''''Class Period''''), are encouraged to contact the firm before December 20, 2021. If you are a shareholder who suffered a loss, click here to participate. We also ..

Stifel Nicolaus upgraded shares of JFrog (NASDAQ:FROG) from a hold rating to a buy rating in a research report report published on Thursday, Price Targets.com reports. They currently have $45.00 price target on the stock. FROG has been the subject of a number of other reports. Morgan Stanley lowered their price objective on JFrog from []

ACADIA Pharmaceuticals (NASDAQ:ACAD) had its price target increased by Mizuho from $24.00 to $26.00 in a research report released on Tuesday, The Fly reports. The brokerage currently has a neutral rating on the biopharmaceutical companys stock. A number of other equities analysts have also recently weighed in on ACAD. Morgan Stanley cut shares of ACADIA []

Summit Materials (NYSE:SUM) had its target price raised by Morgan Stanley from $36.00 to $45.00 in a research report released on Thursday, Analyst Ratings Network reports. They currently have an equal weight rating on the construction company’s stock. A number of other analysts have also issued reports on SUM. Citigroup boosted their price target on […]

Teradata (NYSE:TDC) had its price objective trimmed by Morgan Stanley from $68.00 to $56.00 in a research report report published on Thursday, PriceTargets.com reports. The brokerage currently has an overweight rating on the technology company’s stock. TDC has been the subject of a number of other reports. Cowen upped their price target on shares of […]

Fidelity National Information Services (NYSE:FIS) had its price objective trimmed by Morgan Stanley from $128.00 to $120.00 in a report released on Thursday, Price Targets.com reports. The firm currently has an equal weight rating on the information technology services provider’s stock. Other equities analysts have also issued reports about the stock. TheStreet lowered shares of […]

Coupa Software (NASDAQ:COUP) had its price target lowered by Morgan Stanley from $337.00 to $330.00 in a research report report published on Tuesday, Price Targets.com reports. The brokerage currently has an overweight rating on the technology companys stock. Several other equities analysts have also commented on COUP. Truist lowered their price target on shares of []

Morgan Stanley cut shares of Salzgitter (OTCMKTS:SZGPY) from an equal weight rating to an underweight rating in a report published on Thursday morning, The Fly reports. Other equities analysts have also issued research reports about the stock. Zacks Investment Research lowered shares of Salzgitter from a buy rating to a hold rating in a research []

Morgan Stanley lowered shares of Public Joint Stock Company Polyus (OTCMKTS:OPYGY) from an overweight rating to an equal weight rating in a report released on Thursday, The Fly reports. Shares of Public Joint Stock Company Polyus stock opened at $88.62 on Thursday. Public Joint Stock Company Polyus has a 1 year low of $80.55 and []

Morgan Stanley upgraded shares of Public Joint Stock Company Mining and Metallurgical Company Norilsk Nickel (OTCMKTS:NILSY) from an underweight rating to an equal weight rating in a research note issued to investors on Thursday morning, The Fly reports. A number of other research analysts also recently commented on the stock. AlphaValue raised shares of Public []